JP2005053907A5 - - Google Patents

Download PDF

Info

Publication number
JP2005053907A5
JP2005053907A5 JP2004223680A JP2004223680A JP2005053907A5 JP 2005053907 A5 JP2005053907 A5 JP 2005053907A5 JP 2004223680 A JP2004223680 A JP 2004223680A JP 2004223680 A JP2004223680 A JP 2004223680A JP 2005053907 A5 JP2005053907 A5 JP 2005053907A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
epinastine
pharmaceutical
pharmaceutical composition
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004223680A
Other languages
English (en)
Japanese (ja)
Other versions
JP5021155B2 (ja
JP2005053907A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2005053907A publication Critical patent/JP2005053907A/ja
Publication of JP2005053907A5 publication Critical patent/JP2005053907A5/ja
Application granted granted Critical
Publication of JP5021155B2 publication Critical patent/JP5021155B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2004223680A 2003-08-01 2004-07-30 エピナスチンと１種以上のさらなる抗−ｈ１−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物 Active JP5021155B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03016681.3 2003-08-01
EP03016681 2003-08-01

Publications (3)

Publication Number Publication Date
JP2005053907A JP2005053907A (ja) 2005-03-03
JP2005053907A5 true JP2005053907A5 (hu) 2007-09-13
JP5021155B2 JP5021155B2 (ja) 2012-09-05

Family

ID=34354409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004223680A Active JP5021155B2 (ja) 2003-08-01 2004-07-30 エピナスチンと１種以上のさらなる抗−ｈ１−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物

Country Status (1)

Country Link
JP (1) JP5021155B2 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2472499C2 (ru) * 2007-06-08 2013-01-20 Байер Конзюмер Кер АГ Лекарственное средство, включающее комбинацию активных веществ, содержащую пантотеновую кислоту или ее производные, для лечения аллергических симптомов
JP2019043853A (ja) * 2017-08-30 2019-03-22 旭化成株式会社 経皮吸収促進剤、経皮吸収促進助剤、及び経皮製剤
US20240058356A1 (en) * 2020-12-24 2024-02-22 Santen Pharmaceutical Co., Ltd. Pharmaceutical composition for transdermal administration containing epi-nastine or salt thereof and containing sulfur-based antioxidant
WO2022138826A1 (ja) * 2020-12-24 2022-06-30 参天製薬株式会社 エピナスチン又はその塩を含有する塗布投与用医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4563522B2 (ja) * 1999-02-19 2010-10-13 豊也 加藤 アレルギー疾患治療剤
PE20020324A1 (es) * 2000-10-06 2002-06-18 Boehringer Ingelheim Int Nuevas composiciones farmaceuticas que contienen epinastina y pseudoefedrina
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines

Similar Documents

Publication Publication Date Title
US6221915B1 (en) Pharmaceutical compositions
ES2330873T3 (es) Composicion para dosificacion oral de liberacion prolongada.
ES2226435T3 (es) Metodos de uso y composiciones que comprenden inhibidores de la recaptacion de dopamina.
ES2329971T3 (es) Composicion farmaceutica para la liberacion controlada de paracetamol.
PL207845B1 (pl) Spray donosowy do dostarczania kompozycji farmaceutycznej zawierającej fentanyl i zastosowanie soli fentanylu do wytwarzania środka leczniczego
TW200418474A (en) Method of treating post-operative nausea and vomiting
US11813247B2 (en) NK-1 antagonist compositions and methods for use in treating depression
AU2008259864B2 (en) Methods and compositions for administration of Oxybutynin
Prommer The role of fentanyl in cancer-related pain
RU2005122403A (ru) Композиции нестероидных противовоспалительных лекарственных средств, противозастойных средств и антигистаминов
JP2006515299A5 (hu)
JP2008100924A (ja) 総合感冒薬組み合わせ製剤
CA2846340A1 (en) Treatment of symptoms associated with female gastroparesis
CA3071377C (en) Compositions and methods for improving muscle weakness in patients suffering from myasthenia gravis and other myasthenic syndromes
JP2005053907A5 (hu)
M Farber et al. Design and development of a novel supportive care product for the treatment of sialorrhea in Parkinson’s disease
US20200375957A1 (en) Compositions and method for treating depression
AU2013211546B1 (en) A Medicament
JP4549618B2 (ja) 鼻炎用組成物
US10610507B2 (en) Methods for the treatment of sialorrhea
WO2005063253A1 (ja) アレルギー症状治療用医薬組成物
RU2500399C2 (ru) Комбинированное анальгезирующее и спазмолитическое средство
TW200906406A (en) Use of a compound that is a neurokinin A NK2 receptor antagonist for the preparation of medicaments for use in the prevention and treatment of sexual dysfunctions
JP2004026810A (ja) 鼻炎用組成物